Aberdeen Group plc Sells 135,352 Shares of Cigna Group $CI

Key Points

• Aberdeen Group plc reduced its stake in Cigna Group by 38.3%, now holding 217,642 shares valued at approximately $71.09 million.
• Cigna Group reported a quarterly earnings per share (EPS) of $7.20, surpassing analysts' consensus estimates by $0.05, and achieved a year-over-year revenue increase of 11.0% to $67.13 billion.
• The company has announced a quarterly dividend of $1.51 per share, which translates to an annualized yield of 2.0% and a dividend payout ratio of 32.97%.

Aberdeen Group plc decreased its stake in Cigna Group (NYSE:CI - Free Report) by 38.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 217,642 shares of the health services provider's stock after selling 135,352 shares during the period. Aberdeen Group plc owned 0.08% of Cigna Group worth $71,091,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CI. Massachusetts Financial Services Co. MA boosted its stake in shares of Cigna Group by 0.9% in the first quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider's stock valued at $3,834,493,000 after buying an additional 98,715 shares in the last quarter. GQG Partners LLC boosted its position in shares of Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock worth $1,607,716,000 after purchasing an additional 865,092 shares in the last quarter. Northern Trust Corp grew its stake in shares of Cigna Group by 11.7% during the 4th quarter. Northern Trust Corp now owns 3,140,201 shares of the health services provider's stock worth $867,135,000 after purchasing an additional 328,320 shares during the period. T. Rowe Price Investment Management Inc. purchased a new position in shares of Cigna Group in the 4th quarter valued at about $724,517,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Cigna Group by 15.1% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,495,592 shares of the health services provider's stock valued at $689,133,000 after purchasing an additional 326,633 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.70% of the stock is owned by corporate insiders.

Cigna Group Price Performance

Shares of NYSE CI traded down $1.71 during mid-day trading on Thursday, reaching $302.86. 341,559 shares of the company traded hands, compared to its average volume of 1,847,976. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $370.83. The firm has a market cap of $80.84 billion, a PE ratio of 16.54, a price-to-earnings-growth ratio of 0.88 and a beta of 0.47. The stock has a fifty day simple moving average of $301.44 and a 200-day simple moving average of $311.25. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same quarter in the previous year, the business posted $6.72 earnings per share. The firm's quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th will be given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Thursday, September 4th. Cigna Group's dividend payout ratio is presently 32.97%.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Barclays cut their price objective on Cigna Group from $385.00 to $354.00 and set an "overweight" rating for the company in a research report on Friday, August 1st. Guggenheim reiterated a "buy" rating and issued a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $415.00 target price on Cigna Group and gave the stock a "buy" rating in a report on Tuesday, August 5th. Truist Financial boosted their price target on Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a report on Monday, May 12th. Finally, Cowen restated a "buy" rating on shares of Cigna Group in a research note on Monday, May 5th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $374.82.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.